Research Progress of Celastrol in Obesity
- VernacularTitle: 雷公藤红素治疗肥胖的研究进展
- Author:
Jun-Min FU
1
Author Information
- Publication Type:Journal Article
- Keywords: Adipocyte; Celastrol; Fat metabolism; Leptin sensitivity; Obesity
- From: Chinese Pharmaceutical Journal 2020;55(4):293-297
- CountryChina
- Language:Chinese
- Abstract: Obesity is a kind of metabolic disease, which is a major risk factor of heart disease, diabetes mellitus and cancer. In recent years, the US Food and Drug Administration (FDA) has approved a stand of drugs treatment for obesity, including sibutramine, orlistat, belviq and so on,however, side effects may occur after long-term using. Celastrol is a class of pentacyclic triterpenoids extracted from the roots of Tripterygium wilfordii Hook F. It has been found that celastrol has the pharmacological activities of increasing leptin sensitivity, increasing fat metabolism, inhibiting the formation of lipocyte and inhibiting chronic inflammation in obesity animals. This overview summarizes the related mechanisms of celastrol on treatment of obesity to provide enlightenments for its further study.
